EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, MAZE: Maze Therapeutics Inc

13 Nov 25 11:19
LAST:

31.38

CHANGE:
 1.25		OPEN:
32.18		HIGH:
32.64		ASK:
0.00		VOLUME:
97.3K
CHG(%):
3.83		PREV:
32.63		LOW:
30.60		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
13 Nov 2532.1832.6430.6031.3897.3K
12 Nov 2532.4533.3231.5532.56472.5K
11 Nov 2530.1332.7230.0532.26486.0K
10 Nov 2528.1730.5428.1730.49390.7K
07 Nov 2529.8730.3727.6928.60333.5K
06 Nov 2529.9930.3028.4629.63276.0K
05 Nov 2530.2630.4826.9630.27662.2K
04 Nov 2532.9733.6931.4732.42280.0K
03 Nov 2532.3633.7432.3233.24378.2K
31 Oct 2533.5133.9132.3332.91176.9K

COMPANY PROFILE

Name:Maze Therapeutics Inc
About:Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of renal, cardiovascular, related metabolic diseases, and obesity in the United States. Its lead programs include MZE829, an oral small molecule inhibitor of apolipoprotein L1, or APOL1, which is in phase II clinical trial for the treatment of patients with APOL1 kidney disease; and MZE782, an oral small molecule inhibitor of the solute transporter SLC6A19, which is in phase I clinical trial for the treatment of chronic kidney disease. The company also offers MZE001, a clinical program for the treatment of Pompe disease. Maze Therapeutics, Inc. was formerly known as Modulus Therapeutics, Inc. and changed its name to Maze Therapeutics, Inc. in September 2018. The company was incorporated in 2017 and is based in South San Francisco, California.
Sector:Healthcare
Industry:Biotechnology
Address:171 Oyster Point Blvd, South San Francisco, CA, United States, 94080
Website:https://www.mazetx.com
ISIN:US5787841007
FIGI:BBG00NHJHS27

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:189.50 
Forward P/E:-11.67 
Price to Sales:632.88 
Price to Book:5.50 
Operating Margin:-50.33 
Return on Assets:-0.30 
Return on Equity:-0.63 
EPS Ratio:-1.68 
Revenue:2.5M 
EBITDA:60.88M 
Shares:43.85M 
Market Cap:1.376B 

TECHNICAL INDICATORS

MA5:31.180.6%
MA10:31.440.2%
MA20:30.921.5%
MA50:27.2015.4%
MA100:20.8250.7%
MA200:15.8997.5%
STO9:65.86
STO14:59.49
RSI14:55.57
WPR14:-27.05
MTM14:0.99
ROC14:0.03 
ATR:2.33 
Week High:33.326.2%
Week Low:27.6913.3%
Month High:34.299.3%
Month Low:26.9697.5%